Rain Therapeutics Probability of Future Stock Price Finishing Over 9.36
| RAINDelisted Stock | USD 1.41 0.01 0.70% |
Rain |
Rain Therapeutics Target Price Odds to finish over 9.36
The tendency of Rain Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 9.36 or more in 90 days |
| 1.41 | 90 days | 9.36 | about 5.25 |
Based on a normal probability distribution, the odds of Rain Therapeutics to move over $ 9.36 or more in 90 days from now is about 5.25 (This Rain Therapeutics probability density function shows the probability of Rain Stock to fall within a particular range of prices over 90 days) . Probability of Rain Therapeutics price to stay between its current price of $ 1.41 and $ 9.36 at the end of the 90-day period is about 69.4 .
Given the investment horizon of 90 days Rain Therapeutics has a beta of -0.0457 indicating as returns on the benchmark increase, returns on holding Rain Therapeutics are expected to decrease at a much lower rate. During a bear market, however, Rain Therapeutics is likely to outperform the market. Additionally Rain Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Rain Therapeutics Price Density |
| Price |
Predictive Modules for Rain Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rain Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Rain Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Rain Therapeutics is not an exception. The market had few large corrections towards the Rain Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Rain Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Rain Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.62 | |
β | Beta against Dow Jones | -0.05 | |
σ | Overall volatility | 3.48 | |
Ir | Information ratio | -0.06 |
Rain Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Rain Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Rain Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Rain Therapeutics is not yet fully synchronised with the market data | |
| Rain Therapeutics may become a speculative penny stock | |
| Rain Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (72.26 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Rain Therapeutics currently holds about 90.73 M in cash with (65.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.41, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 68.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Hepion Pharmaceuticals faces Nasdaq delisting risk |
Rain Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Rain Stock often depends not only on the future outlook of the current and potential Rain Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rain Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 28 M | |
| Cash And Short Term Investments | 130.5 M |
Rain Therapeutics Technical Analysis
Rain Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Rain Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Rain Therapeutics. In general, you should focus on analyzing Rain Stock price patterns and their correlations with different microeconomic environments and drivers.
Rain Therapeutics Predictive Forecast Models
Rain Therapeutics' time-series forecasting models is one of many Rain Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Rain Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Rain Therapeutics
Checking the ongoing alerts about Rain Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Rain Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Rain Therapeutics is not yet fully synchronised with the market data | |
| Rain Therapeutics may become a speculative penny stock | |
| Rain Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (72.26 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Rain Therapeutics currently holds about 90.73 M in cash with (65.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.41, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 68.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Hepion Pharmaceuticals faces Nasdaq delisting risk |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Rain Stock
If you are still planning to invest in Rain Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rain Therapeutics' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |